Wagenheim Philip

Wagenheim Philip is listed in filings as Director at Immunome, Inc.. This profile follows SEC Form 4 activity through Mar 23, 2026, including sale activity. Recent filings connect the profile to Immunome, Inc. (IMNM). The current snapshot covers public activity from Jun 18, 2024 to Mar 23, 2026. Reported amounts are shown as $582.3K to $180.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.